Why is J B Chemicals & falling/rising?

As of 25-Sep, J B Chemicals & Pharmaceuticals Ltd is experiencing a decline in its stock price, currently at 1,669.95, reflecting a decrease of 25.3 points or 1.49%. The stock has underperformed its sector today by 0.63% and has been on a consecutive downward trend for the last two days, accumulating a total drop of 3.08%. Additionally, the stock is trading below its 5-day, 20-day, 50-day, 100-day, and 200-day moving averages. Despite high management efficiency indicated by a return on equity (ROE) of 19.49% and a low debt-to-equity ratio of 0.02, the stock's long-term growth prospects appear poor, with an annual operating profit growth rate of only 18.95% over the past five years. The stock's valuation is considered expensive with a price-to-book value of 7.6, and while it has shown some positive financial results, the overall sentiment remains cautious due to its negative returns over the past year.
In the broader market context, J B Chemicals has shown a short-term return of -1.01% over the past week, which is better than the Sensex's decline of 2.23% during the same period. However, the stock has underperformed significantly over the longer term, with a year-to-date return of -9.43% compared to the Sensex's gain of 3.87%. The falling investor participation, evidenced by a 38.25% drop in delivery volume against the 5-day average, further indicates a lack of confidence among investors. Despite high institutional holdings at 37.4%, which typically suggest a strong analytical backing, the stock's recent performance and valuation concerns contribute to its current downward trajectory.